There is limited evidence comparing different antibiotic treatment strategies for patients with clinically suspected community acquired pneumonia patients who are admitted to non-intensive care beds.

A study of 2283 patients in the Netherlands has compared treatment outcomes between patients treated with beta-lactam monotherapy, beta-lactam-macrolide combination therapy and fluroquinolone monotherapy.

In this study beta-lactam monotherapy was found to be non-inferior to other treatment strategies with regard to 90 day mortality.

Read more in the New England Journal of Medicine http://www.nejm.org.acs.hcn.com.au/doi/full/10.1056/NEJMoa1406330